Arcus Biosciences Inc (NYSE:RCUS)
| 15.81 Delayed Data As of 3:59pm ET |  +0.14 / +0.89%Today’s Change | 12.95 Today|||52-Week Range 34.93 | -23.55% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 1.4M | 8.4M | -- | |
| Depreciation And Amortization | 1.3M | 2.6M | 3.7M | -- | ||
| Operating Expenses | Gross Income | -1.3M | -- | -- | -- | |
| General Expenses | 16.9M | 52.2M | 59.5M | -- | ||
| Research And Development | 14.2M | 47.2M | 49.6M | -- | ||
| Total Operating Expenses | 18.2M | 54.9M | 63.2M | -- | ||
| Non-Operating Expenses | Operating Income | -18.2M | -53.4M | -54.9M | -- | |
| Pre-Tax Equity Earnings | -- | -400.0K | -886.0K | -- | ||
| Other Expenses | 0.00 | 0.00 | 6.2M | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -18.0M | -53.1M | -49.6M | -- | |
| Net Income | -18.0M | -53.1M | -49.6M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 43.8M | 43.8M | 34.6M | -- | |
| Shares To Calculate EPS Diluted | 43.8M | 43.8M | 34.6M | -- | ||
| Earnings Per Share | EPS | -$0.41 | -$1.21 | -$1.43 | -- | |
| EPS Diluted | -$0.41 | -$1.21 | -$1.43 | -- | ||
